These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21949023)

  • 1. The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance.
    D'Addio F; Riella LV; Mfarrej BG; Chabtini L; Adams LT; Yeung M; Yagita H; Azuma M; Sayegh MH; Guleria I
    J Immunol; 2011 Nov; 187(9):4530-41. PubMed ID: 21949023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A link between PDL1 and T regulatory cells in fetomaternal tolerance.
    Habicht A; Dada S; Jurewicz M; Fife BT; Yagita H; Azuma M; Sayegh MH; Guleria I
    J Immunol; 2007 Oct; 179(8):5211-9. PubMed ID: 17911606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of PD1/PDL1 pathway, and TH17 and treg cells in maternal tolerance to the fetus.
    Tripathi S; Guleria I
    Biomed J; 2015; 38(1):25-31. PubMed ID: 25355392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical role for the programmed death ligand 1 in fetomaternal tolerance.
    Guleria I; Khosroshahi A; Ansari MJ; Habicht A; Azuma M; Yagita H; Noelle RJ; Coyle A; Mellor AL; Khoury SJ; Sayegh MH
    J Exp Med; 2005 Jul; 202(2):231-7. PubMed ID: 16027236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo.
    Yang J; Riella LV; Chock S; Liu T; Zhao X; Yuan X; Paterson AM; Watanabe T; Vanguri V; Yagita H; Azuma M; Blazar BR; Freeman GJ; Rodig SJ; Sharpe AH; Chandraker A; Sayegh MH
    J Immunol; 2011 Aug; 187(3):1113-9. PubMed ID: 21697455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection.
    Vokaer B; Van Rompaey N; Lemaître PH; Lhommé F; Kubjak C; Benghiat FS; Iwakura Y; Petein M; Field KA; Goldman M; Le Moine A; Charbonnier LM
    J Immunol; 2010 Sep; 185(6):3417-25. PubMed ID: 20733201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.
    Luz-Crawford P; Noël D; Fernandez X; Khoury M; Figueroa F; Carrión F; Jorgensen C; Djouad F
    PLoS One; 2012; 7(9):e45272. PubMed ID: 23028899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo.
    Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Domenig C; Habicht A; Najafian N; Yagita H; Azuma M; Turka LA; Sayegh MH
    J Immunol; 2005 Mar; 174(6):3408-15. PubMed ID: 15749874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.
    Zhen Y; Yao L; Zhong S; Song Y; Cui Y; Li S
    Arch Dermatol Res; 2016 Dec; 308(10):703-710. PubMed ID: 27687555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloantigen specific T regulatory cells in transplant tolerance.
    Hall BM; Tran G; Hodgkinson SJ
    Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells.
    Carter NA; Vasconcellos R; Rosser EC; Tulone C; Muñoz-Suano A; Kamanaka M; Ehrenstein MR; Flavell RA; Mauri C
    J Immunol; 2011 May; 186(10):5569-79. PubMed ID: 21464089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7h (ICOS-L) maintains tolerance at the fetomaternal interface.
    Riella LV; Dada S; Chabtini L; Smith B; Huang L; Dakle P; Mfarrej B; D'Addio F; Adams LT; Kochupurakkal N; Vergani A; Fiorina P; Mellor AL; Sharpe AH; Yagita H; Guleria I
    Am J Pathol; 2013 Jun; 182(6):2204-13. PubMed ID: 23578385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of PD-1/PD-L1 Signaling Pathway with Treg/Th17 Imbalance from Asthmatic Children.
    Xi X; Liu JM; Guo JY
    Int Arch Allergy Immunol; 2018; 176(3-4):255-267. PubMed ID: 29874664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4(+)Foxp3(+) T and IL-17(+)CD4(+) Th17 cells.
    Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Eo SK
    J Neuroinflammation; 2016 Jul; 13(1):223. PubMed ID: 27439902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cell subset differentiation and avidity setpoint are dictated by the interplay of cytokine and antigen mediated signals.
    Shiner EK; Holbrook BC; Alexander-Miller MA
    PLoS One; 2014; 9(6):e100175. PubMed ID: 24940899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boswellic acids reduce Th17 differentiation via blockade of IL-1β-mediated IRAK1 signaling.
    Stürner KH; Verse N; Yousef S; Martin R; Sospedra M
    Eur J Immunol; 2014 Apr; 44(4):1200-12. PubMed ID: 24469975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential requirements for Th1 and Th17 responses to a systemic self-antigen.
    Katzman SD; Gallo E; Hoyer KK; Abbas AK
    J Immunol; 2011 Apr; 186(8):4668-73. PubMed ID: 21402892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-7 drives Th1 and Th17 cytokine production in patients with primary SS despite an increase in CD4 T cells lacking the IL-7Rα.
    Bikker A; Moret FM; Kruize AA; Bijlsma JW; Lafeber FP; van Roon JA
    Rheumatology (Oxford); 2012 Jun; 51(6):996-1005. PubMed ID: 22302060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.